PMC · DOI:10.3389/fimmu.2025.1760910·December 22, 2025
Editorial: Immune-checkpoint inhibitors and immunometabolic reprogramming in cancer immunotherapy
Vijay Kumar, Valentina De Falco
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Diseases1
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Immunotherapy and Biomarkers · Immune cells in cancer · Cancer, Hypoxia, and Metabolism